[1]
2022. Clinical Evaluation of T-AYU-HM Premium in Sickle cell Anemia Patients: A Retrospective Study. International Journal of Ayurveda and Pharma Research. 10, Suppl2 (Oct. 2022), 28–35. DOI:https://doi.org/10.47070/ijapr.v10iSuppl2.2554.